Avelo Starts AeroCAP Pneumonia Study with University Hospital Basel
November 12, 2024. Avelo starts its pneumonia study, AeroCAP, in collaboration with Prof. Dr. med. Michael Osthoff and his team at...
top of page
Avelo Takes Part in ‘BreathForDx’, a EUR 3M Horizon Project Revolutionizing Respiratory Diagnosis
May 13, 2024. Avelo joins forces with esteemed research partners from the University Hospital Heidelberg (UKHD), Ospedale San Raffaele,...
Avelo receives CHF 10,000 Prize Money from ZKB Pionierpreis
May 7, 2024. Avelo, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease diagnosis,...
Are you interested?
to join our passionate team of superheros in Schlieren, Switzerland Our Mission: Saving Patient Lives with AveloCollect At Avelo, we are...
Avelo receives CHF 1.5M Innosuisse Grant to Deliver an Innovative Breath Sampling Tool for LRTIs
December 14, 2023. The Swiss breath diagnostics start-up, Avelo, announces that they have received a CHF 1.5M Innosuisse Grant to realize...
Avelo, VIVOLTA, and BLINK win €1.5M Eurostars grant to develop new solution for diagnosing LRTI
October 26, 2023. Avelo, VIVOLTA, and BLINK today announced they have won a €1.5M Eurostars grant to develop a new solution for...
Avelo is One of Top Newcomers of the Top 100 Swiss Startup Award
September 7, 2023. Avelo, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease...
Avelo Appoints Highly Experienced Board of Directors
October 6, 2022. Avelo AG, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease...
Avelo closes CHF 2.2 million oversubscribed seed round
The funds will accelerate the clinical validation of the breath collector for non-invasive sampling of patients with Tuberculosis and...
Swiss Handelzeitung's Upbeat features Avelo
June 30, 2022. Learn more about Avelo and its CEO's entrepreneurial motivation here.
Avelo wins CHF 150'000 from VentureKick
June 29, 2022. Avelo wins CHF 150,000 from VentureKick to make every breath count for better respiratory disease diagnosis. The company...
Avelo and its partners receive Innosuisse grant for more efficient Tuberculosis diagnosis
June 15, 2022. Avelo, in collaboration with the research team at the Zurich University of Applied Sciences (ZHAW) and researchers from...
Avelo Appoints Scientific Advisory Board
January 15, 2021. Avelo Inc. welcomes four highly regarded experts in global health, infectious disease diagnostics development,...
bottom of page